On Friday, Shares of Cempra Inc (NASDAQ:CEMP), lost -27.97% to $19.29. The stock attained the volume of 22.48 million shares.
Cempra, Inc. (CEMP) declared positive topline results from a global, pivotal Phase 3 clinical trial of intravenous (IV) to oral solithromycin (Solitaire-IV) in the treatment of patients with community-attained bacterial pneumonia (CABP).
In the intent-to-treat population (ITT, all randomized patients), solithromycin met the FDA primary objective of statistical non-inferiority (NI, 10% non-inferiority margin) contrast to moxifloxacin at the early clinical response (ECR, 72 [-12/+36] hours after initiation of therapy). The point estimates for the primary endpoint of early clinical response were 79.3% for solithromycin and 79.7% for moxifloxacin. The 95% confidence interval for the treatment difference had lower and upper bounds of -6.1% and 5.2%, respectively.
Solithromycin also met the co-primary objective of statistical NI contrast to moxifloxacin at the ECR in the microbiological ITT (mITT) population (those patients with an etiologic diagnosis of the cause of CABP) from the pooled data from both Phase 3 studies. The point estimates were 77.2% for solithromycin and 78.9% for moxifloxacin with lower and upper bounds of the 95% confidence interval for the treatment difference of -7.4% and 4.2%.
Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases in North America. Its lead product candidates comprise solithromycin (CEM-101), which is in Phase III clinical trials for the treatment of community attained bacterial pneumonia, in addition to for uncomplicated bacterial urethritis; and Taksta (CEM-102), an antibiotic that has accomplished Phase II clinical trials for refractory bone and joint infections.
Shares of Ford Motor Company (NYSE:F), surged 0.33% to $15.27, during its last trading session.
Ford Motor Company is expanding its commitment in New England by launching a new philanthropic initiative with local dealers that will comprise $2 million to fight hunger across the region.
Ford Motor Company Fund, the charitable arm of Ford Motor Company, will provide support, counting vehicles, to 10 food banks in Connecticut, Maine, Massachusetts, New Hampshire, New York, Rhode Island and Vermont over five years. Ford is working with Feeding America®, the nation’s leading domestic hunger-relief organization, in connection with its outreach in New England.
Over the last decade, Ford has assisted provide more than 100 additional vehicles to Feeding America member food banks. These vehicles enable food banks to collect food and grocery donations received from retail stores, farmers and manufacturers and get it to people facing hunger.
Ford Motor Company manufactures and distributes automobiles worldwide. The company operates through two sectors, Automotive and Financial Services. The Automotive sector develops, manufactures, distributes, and services vehicles, parts, and accessories. It offers vehicles primarily under the Ford and Lincoln brand names.
Finally, Advanced Micro Devices, Inc. (NASDAQ:AMD), ended its last trade with -1.52% loss, and closed at $1.94.
AMD ( AMD) and Nantong Fujitsu Microelectronics Co., Ltd (NFME) (SZSE: TFWD) declared the signing of a definitive agreement to create a joint venture combining AMD’s high-volume assembly, test, mark, and pack (ATMP) facilities and practiced workforce in Penang, Malaysia and Suzhou, China with NFME’s established outsourced semiconductor assembly and test (OSAT) expertise. Upon close, the new business will leverage the capabilities of 5 facilities and about 5,800 employees to offer differentiated ATMP capabilities and scale to service a broad range of customers. The transaction is predictable to close in the first half of 2016, pending successful completion of regulatory approvals.
Shi Lei, the general manager of NFME, said, “AMD has world-class advanced assembly and testing facilities and a rich history of high-volume production. AMD’s technology and expertise is very complementary to our current capabilities. The newly-formed JV will improve NFME’s R&D capability and enhance our corporate reputation worldwide. The JV will also strengthen our opportunities to further move into international markets and secure additional customers as a part of our plans to become one of the world’s leading assembly and testing companies.”
The joint venture marks another step in AMD’s planned plan to sharpen its focus on building great products while enhancing the company’s supply chain operations in the long run by providing additional scale and strengthening its balance sheet through a cash infusion and reduced capital expenditures aligned with a fabless business model.
Advanced Micro Devices, Inc. is a global semiconductor company with facilities across the world. The Company offers x86 microprocessors, as standalone devices or as incorporated as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs) and professional graphics, and server and embedded processors, dense servers, semi-custom System-on-Chip (SoC) products and technology for game consoles.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
